恶性血液病患者游离Fas的检测及临床意义

首都医科大学学报 ›› 2000, Vol. 21 ›› Issue (1): 43-45.

恶性血液病患者游离Fas的检测及临床意义

郑佳, 刘复强, 翟艳玲, 刘元波, 王天, 李守静, 赵相印

首都医科大学附属北京同仁医院血液科

收稿日期:1999-02-06 修回日期:1900-01-01 出版日期:2000-01-15 发布日期:2000-01-15

The Serum Levels of Soluble Fas in Patients with Malignant Hematologic Diseases and its Clinical Implication

Zheng Jia, Liu Fuqiang, Zhai Yanling, Liu Yuanpo, Wang Tian, Li Shoujing, Zhao Xiangyin

Department of Hematology, Beijing Tongren Hospital, Affiliate of Capital University of Medical Sciences

Received:1999-02-06 Revised:1900-01-01 Online:2000-01-15 Published:2000-01-15

摘要/Abstract

摘要： 为了解游离Fas(sFas)在恶性血液病中的水平及临床意义,用酶联免疫吸附法测定了60例恶性血液病患者的血清sFas.结果：恶性血液病患者血清sFas质量浓度高于正常人(P<0.01),治疗后sFas下降,下降的程度与疗效有关,但治疗前sFas质量浓度的高低与疗效预测无关。结果提示：sFas对恶性血液病的诊断及疗效判定有一定意义,并可能对其发病机制产生影响。

关键词: 游离Fas, 恶性血液病, 细胞凋亡

Abstract: In order to study the serum levels of soluble Fas (sFas) in malignant hematologic diseases and its clinical implication, serum levels of sFas in 60 patients with malignant hematologic diseases and in a control group of 30 health volunteers were measured by sandwich enzyme linked immunosorbent assay (ELISA) method.Before chemotherapy, the serum levels of sFas in patients with malignant hematologic diseases were significantly higher than those of control group(P<0.01), and were not related to respose to chemotherapy. After chemotherapy, the levels of sFas significantly lowered in complete remission (CR) group (P<0.05), but did not in unremission (NR) group. The levels and changes of sFas might be served as a reference finger to diagnosis some malignant hematologic diseases and to evaluate chemotherapy effect. sFas might be involved in pathogenesis of some malignant hematologic diseases .

Key words: soluble Fas, malignant hematologic diseases, apoptosis

中图分类号:

R733

郑佳;刘复强;翟艳玲;刘元波;王天;李守静;赵相印. 恶性血液病患者游离Fas的检测及临床意义[J]. 首都医科大学学报, 2000, 21(1): 43-45.

Zheng Jia;Liu Fuqiang;Zhai Yanling;Liu Yuanpo;Wang Tian;Li Shoujing;Zhao Xiangyin. The Serum Levels of Soluble Fas in Patients with Malignant Hematologic Diseases and its Clinical Implication[J]. Journal of Capital Medical University, 2000, 21(1): 43-45.

[1]	安松林, 马玲, 赵月, 李雁. 主要促进因子超家族成员MFSD2A对肝癌细胞增殖、凋亡和侵袭的影响[J]. 首都医科大学学报, 2021, 42(6): 1000-1006.
[2]	张怡尘, 曹曦, 杨金奎. G蛋白偶联受体MAS对肝脏糖脂代谢的影响[J]. 首都医科大学学报, 2019, 40(3): 409-416.
[3]	宋丽妮, 曹曦, 刘薇, 杨金奎. 血管紧张素转化酶2对肝细胞凋亡的影响[J]. 首都医科大学学报, 2018, 39(2): 223-229.
[4]	穆凌云, 李金霞, 张秋云, 陈煜, 高连印, 杜宇琼. 截断逆挽方对慢加急性肝衰竭模型大鼠血清TNF-α、肝组织p-JNK及c-Jun的影响[J]. 首都医科大学学报, 2017, 38(2): 282-288.
[5]	王梦然, 张健, 梁艳红, 陈艳蓉, 李敏, 肖瑶, 宿慧. 缺血后处理对老年大鼠心肌缺血再灌注损伤的保护作用[J]. 首都医科大学学报, 2015, 36(1): 132-136.
[6]	叶娜, 董晓英, 李冬华. 卵巢早衰的颗粒细胞凋亡机制研究进展[J]. 首都医科大学学报, 2014, 35(3): 379-383.
[7]	王鹏雁;安建多;王池;王学从;武鑫瑞;王学江. 槲芪散及槲寄生提取物对肝癌细胞内游离钙离子浓度的影响[J]. 首都医科大学学报, 2012, 33(3): 291-296.
[8]	廖秋菊;王晶;秦俭. 胰岛素防治大鼠一氧化碳中毒迟发性脑病的实验研究[J]. 首都医科大学学报, 2012, 33(2): 233-237.
[9]	王燕;李萍;林燕;赵京霞;刘欣;何薇;梁代英;罗晓琴;王笑民. 鸡血藤黄酮类有效部位对人非小细胞肺癌A549细胞凋亡与线粒体膜电位的影响[J]. 首都医科大学学报, 2011, 32(6): 811-815.
[10]	丁月霞;;张丽;叶翠飞;王文;李林. 山茱萸环烯醚萜苷对穹隆海马伞切断大鼠海马区神经元存活和细胞凋亡调控因子的影响[J]. 首都医科大学学报, 2011, 32(1): 73-78.
[11]	王宏艳;常瑛. 重组可溶性TRAIL联合化疗药诱导急性白血病细胞凋亡[J]. 首都医科大学学报, 2008, 29(3): 364-368.
[12]	刘欣;曾少举;王永潮. 分化抑制因子Id4对K562细胞株凋亡的影响[J]. 首都医科大学学报, 2006, 27(5): 607-611.
[13]	万岁桂;孙雪静;刘聪艳;赵弘;徐娟;田丁. 再生障碍性贫血患者骨髓CD34⁺和Fas⁺细胞Fas抗原的表达[J]. 首都医科大学学报, 2002, 23(2): 128-130.
[14]	秦明照;王国宏;翟艳玲;田海玲. 慢性充血性心力衰竭患者sFas及TNF观察[J]. 首都医科大学学报, 2000, 21(4): 307-308.
[15]	赵性泉;龙洁;张在强;李小玲;王群. 大鼠局灶性脑缺血半暗带细胞凋亡动态变化规律的研究[J]. 首都医科大学学报, 2000, 21(1): 26-28.